Skip to main content
. 2014 Sep;52(9):3377–3383. doi: 10.1128/JCM.00593-14

FIG 3.

FIG 3

Distribution of VL among 284 patients receiving ART and 70 untreated individuals in Malawi and Uganda. VL was determined with Roche TaqMan v2.